Skip to main content
HR 6110 115th Congress House Health Alternative treatments Congressional oversight Drug therapy Drug trafficking and controlled substances Drug, alcohol, tobacco use Fraud offenses and financial crimes Government information and archives Government studies and investigations Health care coverage and access Health facilities and institutions Health personnel Health programs administration and funding Health promotion and preventive care Health technology, devices, supplies Home and outpatient care Hospital care Medicare Mental health Military medicine

Dr. Todd Graham Pain Management, Treatment, and Recovery Act of 2018

Introduced: June 14, 2018 See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 10 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 25, 2018
Referred to the Subcommittee on Health.
Jun 20, 2018
Received in the Senate and Read twice and referred to the Committee on Finance.
Jun 19, 2018
Motion to reconsider laid on the table Agreed to without objection.
Jun 19, 2018
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H5250-5252)
Jun 19, 2018
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H5250-5252)
Jun 19, 2018
DEBATE - The House proceeded with forty minutes of debate on H.R. 6110.
Jun 19, 2018
Considered under suspension of the rules. (consideration: CR H5249-5254)
Jun 19, 2018
Mrs. Walorski moved to suspend the rules and pass the bill.
Jun 14, 2018
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jun 14, 2018
Introduced in House
 Plain-English summary Congressional Research Service

Dr. Todd Graham Pain Management, Treatment, and Recovery Act of 2018

This bill establishes several requirements for the Centers for Medicare & Medicaid Services (CMS), and alters requirements under Medicare and Medicare Advantage (MA), related to pain management and opioid use.

Among other requirements, the CMS must review payments under Medicare for opioid and non-opioid pain management procedures, specifically with respect to ambulatory outpatient surgical procedures and hospital outpatient department services. The CMS must ensure that there are no payment incentives for using opioids instead of non-opioid alternatives and must make revisions accordingly.

The bill also requires payment under Medicare to federally qualified health centers and rural health clinics that have health care practitioners who are newly certified to provide medication-assisted treatment (e.g., buprenorphine).

The bill also authorizes the suspension of payments to a pharmacy under the Medicare prescription drug benefit and MA prescription drug plans pending the investigation of a credible allegation of fraud by the pharmacy.

What's happening now June 25, 2018

Referred to the Subcommittee on Health.

 Committees of jurisdiction 4
 Cosponsors 3
All 3 Democratic 3